Nasdaq Stockholm

AlzeCure Pharma AB

At a glance

Most recent filing on December 4, 2020 — an open-market purchase by Birgitta Kristina Olofsdotter Lundvik on Dec 2, 2020.

We hold 4 visible filings, going back to August 28, 2020.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

What is a MAR filing?

All 4 shown

This page is free to read, and it stops after 4 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Birgitta Kristina Olofsdotter Lundvik Chief financial officer
95,600 SEKOpen-market buy
TradedDec 2, 2020FiledDec 4, 2020
Oncolution AB Closely associated: Chair of the board
732,800 SEKOpen-market buy
TradedDec 2, 2020FiledDec 2, 2020
Martin Jönsson Chief executive officer
954,720 SEKOpen-market buy
TradedOct 16, 2020FiledOct 18, 2020
Pirkko Vilja Päivikki Sulila Tamsen Board member or deputy board member
92,300 SEKOpen-market buy
TradedAug 28, 2020FiledAug 28, 2020